Pfizer begins mid-to-late-stage study for Covid-19 antiviral drug

Pfizer said this therapy, if worked, could help stop the virus early – before it has had a chance to replicate extensively – potentially preventing symptomatic disease

from mint - Science https://ift.tt/3ERA6Y5